Fixed combinations of glaucoma medications

Srpski arhiv za celokupno lekarstvo ◽

10.2298/sarh1510626b ◽

2015 ◽

Vol 143 (9-10) ◽

pp. 626-631 ◽

Author(s):

Nikola Babic

Keyword(s):

Intraocular Pressure ◽

Fixed Combination ◽

Pressure Control ◽

Line Treatment ◽

Efficacy And Safety ◽

Advantages And Disadvantages ◽

Role Efficacy ◽

Indications For Use ◽

First Line Treatment

The first line treatment in the management of glaucoma is topical medical therapy. Many patients with glaucoma require multiple medications for adequate intraocular pressure control. For patients who need multi-dose regimens to control intraocular pressure, fixed combinations offer convenience, efficacy and safety. This review summarizes the role, efficacy, mechanism of action and indications for use of modern fixed combination of topical glaucoma medications. The review shows the advantages and disadvantages of a prescribing fixed combination in daily clinical practice.

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

Gastric Cancer ◽

10.1007/s10120-011-0009-5 ◽

2011 ◽

Vol 14 (1) ◽

pp. 72-80 ◽

Author(s):

Hiroyuki Narahara ◽

Hiroyasu Iishi ◽

Hiroshi Imamura ◽

Akira Tsuburaya ◽

Keisho Chin ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

Cancer Study ◽

Gastric Cancer Study ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Efficacy and safety of tislelizumab, an anti-PD-1 antibody, versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma in a phase 3, randomized, open-label, multicenter study - Trial in progress

Annals of Oncology ◽

10.1093/annonc/mdy151.181 ◽

2018 ◽

Vol 29 ◽

pp. v51

Author(s):

S. Qin ◽

R. Finn ◽

M. Kudo ◽

T. Meyer ◽

A. Vogel ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Multicenter Study ◽

Study Trial ◽

Advanced Hepatocellular Carcinoma ◽

Line Treatment ◽

Efficacy And Safety ◽

Phase 3 ◽

First Line Treatment

Download Full-text

Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s103954 ◽

2016 ◽

Vol Volume 9 ◽

pp. 3771-3781 ◽

Author(s):

Xiao-Qun Liu ◽

Xiangdong Liu ◽

Tiankui Qiao ◽

Wei Chen ◽

Sujuan Yuan

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Controlled Trials ◽

Line Treatment ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Locally Recurrent ◽

First Line Treatment

Download Full-text

Efficacy and safety of immunological checkpoint inhibitors combined with anti-angiogenic drugs in first-line treatment of metastatic renal cell carcinoma: a systematic review and meta-analysis

Translational Andrology and Urology ◽

10.21037/tau-20-969 ◽

2021 ◽

Vol 10 (1) ◽

pp. 300-309

Author(s):

Yingwei Xie ◽

Zhiliang Chen ◽

Qiyu Zhong ◽

Yuqing Chen ◽

Wentai Shangguan ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line Treatment

Download Full-text

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30413-9 ◽

2019 ◽

Vol 20 (10) ◽

pp. 1370-1385 ◽

Author(s):

Robert J Motzer ◽

Brian I Rini ◽

David F McDermott ◽

Osvaldo Arén Frontera ◽

Hans J Hammers ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Line Treatment ◽

Efficacy And Safety ◽

Phase 3 ◽

Randomised Controlled ◽

First Line Treatment

Download Full-text

A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction

British Journal of Haematology ◽

10.1111/j.1365-2141.2011.08602.x ◽

2011 ◽

Vol 154 (2) ◽

pp. 271-274 ◽

Author(s):

Emanuele Cencini ◽

Elisa Sozzi ◽

Anna Sicuranza ◽

Alberto Fabbri ◽

Donatella Raspadori ◽

...

Keyword(s):

Elderly Patients ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line Treatment

Download Full-text

1450P Efficacy and safety analysis of modified biweekly SOX regimen in the first-line treatment of advanced gastric adenocarcinoma or esophagogastric junction adenocarcinoma

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1956 ◽

2020 ◽

Vol 31 ◽

pp. S911

Author(s):

S. Zhang ◽

H. Wang ◽

Y. Meng ◽

X. Nie ◽

C. Huang ◽

...

Keyword(s):

Gastric Adenocarcinoma ◽

Esophagogastric Junction ◽

Safety Analysis ◽

Line Treatment ◽

Efficacy And Safety ◽

Esophagogastric Junction Adenocarcinoma ◽

Advanced Gastric Adenocarcinoma ◽

First Line Treatment

Download Full-text

Comparative Study of Efficacy and Safety of Ciprofloxacin and Cefixime in the Treatment of Acute Exacerbations of Chronic Bronchitis after First-Line Treatment Failure

Drugs ◽

10.2165/00003495-199500492-00122 ◽

1995 ◽

Vol 49 (Supplement 2) ◽

pp. 423-425

Author(s):

G. Nouvet ◽

K. Benmessaoud

Keyword(s):

Comparative Study ◽

Treatment Failure ◽

Chronic Bronchitis ◽

Line Treatment ◽

Efficacy And Safety ◽

Acute Exacerbations ◽

First Line Treatment

Download Full-text

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a010544 ◽

1996 ◽

Vol 7 (2) ◽

pp. 165-171 ◽

Author(s):

P. Fumoleau ◽

B. Chevallier ◽

P. Kerbrat ◽

Y. Krakowski ◽

J.-L. Misset ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Efficacy And Safety ◽

Clinical Screening ◽

Multicentre Phase ◽

First Line Treatment

Download Full-text